Zixing Artificial Intelligence (Shenzhen) Co., Ltd
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Zixing Artificial Intelligence (Shenzhen) Co., Ltd - overview
Established
2016
Location
Shenzhen, Guangdong, China
Primary Industry
Healthcare IT
About
Based in Shenzhen, China, and founded in 2016, Zixing Artificial Intelligence (Shenzhen) Co. , Ltd is an artificial intelligence technology-based enterprise focusing on the fields of tumor, reproduction and genetics. Its main product, karyotype intelligent analysis system, is applied in the field of reproduction and genetics, hematology, and oncology. It provides AI-assisted diagnostic capability for chromosome technology in the diagnosis and prognosis judgment of various diseases.
It has been applied in dozens of hospitals in 16 provinces and 24 cities.
Primary Industry
Healthcare IT
Sub Industries
Healthcare IT, Oncology/Cancer Treatment
Verticals
Artificial Intelligence, HealthTech
Company Stage
Series A
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.